Min Li
CEO & Director
Min brings more than 30 years of leadership experience from academia, and in the biopharmaceutical and venture capital industries in both the US and China. His extensive knowledge and insights of the field neuroscience led to the founding of SciNeuro Pharmaceuticals in late 2020 to tackle the development of innovative therapeutics for CNS diseases. Min also currently serves as a venture partner at LAV. Prior to joining LAV, he was senior vice president and therapeutic area head for neurosciences R&D at GSK, and general manager of R&D China. Earlier In his career, Dr. Li was a full professor in neuroscience at Johns Hopkins University School of Medicine. He holds a Ph.D. in molecular immunology from Johns Hopkins; received postdoctoral training in neuroscience from University of California San Francisco.
